Escozine™ is a natural supplement, made from scorpion venom, which is currently being used to help
- Non malignant tumours
- Hepatitis C
- Multiple sclerosis
- Alzheimer’s disease
- Parkinson’s disease
- and HIV
improve their health at a deep cellular level. It can also be used to treat animals. Escozine™ is a very flexible product and can be taken as a supplement to chemotherapy and radiotherapy or with natural treatments or on its own as recommended by your medical adviser. It is colourless and odourless and can be administered orally and can be used by anyone in the convenience of their home. One bottle is used for 30 days of intake.
How it works
Escozine™ acts as a sodium, potassium and chloride ionic channel inhibitor. The protected polarizing technology ensures binding by increasing the positive charges in chlorotoxin up to five times the normal amount which is why it acts like a “smart missile” and effectively targets only abnormal cells, leaving healthy cells unharmed.
11 years of pre-clinical studies and clinical observation at Moores Cancer Centre (UC San Diego) demonstrate that Escozine™ has a strong synergistic effect when used alongside chemotherapy – both products work against cancer cells and as such their effectiveness multiplies.
Because Escozine™ also has immune-system enhancement capabilities, our oncologists and scientists noticed an increase of T-cell function in the body during clinical observations. This also works as a protective mechanism for the patient as they go through chemotherapy. It helps them go through the chemotherapy process with less side-effects. We are also noticing a similar effect with radiotherapy as well.
Although Escozine™ can be taken instead of replacement treatments we do not encourage patients to refuse conventional treatments. That is something which the patient should do with their their healthcare provider or nutritionist.
Made from blue scorpion serum, Escozine™ is in research and development as an advanced anti-cancer drug.
The manufacturers of Escozine™, are currently preparing to apply to the FDA (Food and Drug Administration) for clinical trials in the United States for Escozine GNP-1. The FDA application approach has been validated by a study done in the University of Massachusetts Amherst (UMass Amherst). It suggests that anti-cancer chemotherapies which use gold nanoparticles to deliver chemotherapy drugs deep inside tumour tissues will be more effective if the particles are positively electrically charged; this causes the particles to be more attracted to proliferating cells, according to a team of chemists and chemical engineers at UMass Amherst.
A copy of our patent is available here
To visit our Facebook page click here
This page has been created to inform Members of Parliament, local authorities, registered medical practitioners, registered nurses, registered pharmacists and authorised sellers of poisons, persons undergoing training with a view to become registered medical practitoners, registered nurses and registered pharmacists about the neutraceutical Escozine and studies about the effectiveness of this product.
This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.